These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 5499317)

  • 21. Comparative persistence of capillary tube-agglutination and complement-fixation test reactions in cattle treated to destroy the carrier state of anaplasmosis.
    Jatkar PR; Kreier JR; Akin EL; Tharp V
    Am J Vet Res; 1966 Jan; 27(116):372-4. PubMed ID: 5950165
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of estrogens upon Anaplasma marginale infection in splenectomized cattle.
    Klaus G; Jones EW; Kliewer IO
    Am J Vet Res; 1967 Jul; 28(125):1033-6. PubMed ID: 6065933
    [No Abstract]   [Full Text] [Related]  

  • 23. The inhibitory effect of imidocarb on experimental anaplasmosis in splenectomized calves.
    Roby TO
    Res Vet Sci; 1972 Nov; 13(6):519-22. PubMed ID: 4648992
    [No Abstract]   [Full Text] [Related]  

  • 24. A preliminary evaluation of a dithiosemicarbazone for the treatment of anaplasmosis.
    Kuttler KL; Zaraza H
    Res Vet Sci; 1970 Jul; 11(4):334-8. PubMed ID: 5499316
    [No Abstract]   [Full Text] [Related]  

  • 25. Ultrastructural and fluorochromatic changes of Anaplasma marginale exposed to oxytetracycline, imidocarb and enrofloxacin in short-term erythrocyte cultures.
    Coetzee JF; Kocan KM; Higgins JJ; Apley MD; Jones DE
    Vet Microbiol; 2009 Apr; 136(1-2):45-53. PubMed ID: 19054634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemotherapy of experimental Anaplasma marginale infections. Trials with an experimental dithiosemicarbazone (alpha-ethoxyethylglyoxal dithiosemicarbazone).
    Brown CG; Wilde JK; Berger J
    Br Vet J; 1968 Aug; 124(8):325-34. PubMed ID: 5671949
    [No Abstract]   [Full Text] [Related]  

  • 27. Efficacy of long-acting oxytetracycline and imidocarb dipropionate for the chemosterilization of Anaplasma marginale in experimentally infected carrier cattle in Argentina.
    Sarli M; Novoa MB; Mazzucco MN; Morel N; Primo ME; de Echaide ST; Echaide IE
    Vet Parasitol Reg Stud Reports; 2021 Jan; 23():100513. PubMed ID: 33678368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of dexamethasone on the recrudescence of Anaplasma marginale in splenectomized calves.
    Kuttler KL; Adams LG
    Am J Vet Res; 1977 Sep; 38(9):1327-30. PubMed ID: 921027
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunity to bovine anaplasmosis after elimination of the carrier status with oxytetracycline hydrochloride.
    Renshaw HW; Magonigle RA; Eckblad WP; Frank FW
    Proc Annu Meet U S Anim Health Assoc; 1976; (80):79-88. PubMed ID: 1078098
    [No Abstract]   [Full Text] [Related]  

  • 30. Bovine anaplasmosis: clinical, hematologic, and serologic manifestations in cows given a long-acting oxytetracycline formulation in the prepatent period.
    Lincoln SD; Eckblad WP; Magonigle RA
    Am J Vet Res; 1982 Aug; 43(8):1360-2. PubMed ID: 7103219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Application of various chemotherapeutic agents in experimental bovine anaplasmosis.
    Sharma SK; Banerjee DP; Gautam OP
    Ann Rech Vet; 1977; 8(3):307-13. PubMed ID: 606144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Infection of splenectomized calves with Anaplasma ovis.
    Kuttler KL
    Am J Vet Res; 1981 Dec; 42(12):2094-6. PubMed ID: 7340580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A case of apparent suppression of Anaplasma marginale infection by eperythrozoonosis (Eperythrozoon teganodes).
    Hadani A; Guglielmone AA; Anziani OS; Tarablas H; Mangold A; Bermudez A; Castor JC; Gonzalez de Rios L
    Vet Parasitol; 1982 Feb; 9(3-4):267-72. PubMed ID: 6211820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anaplasma ovis in Idaho sheep.
    Magonigle RA; Eckblad WP; Lincoln SD; Frank FW
    Am J Vet Res; 1981 Feb; 42(2):199-201. PubMed ID: 7258767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serologic and clinical responses of premunized, vaccinated, and previously infected cattle to challenge exposure by two different Anaplasma marginale isolates.
    Kuttler KL; Zaugg JL; Johnson LW
    Am J Vet Res; 1984 Nov; 45(11):2223-6. PubMed ID: 6084430
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anaplasmosis: prevalence, treatment, and cattle to elk transmission studies.
    Renshaw HW; Magonigle RA; Stauber EH; Vaughn HW; Frank FW
    Proc Annu Meet U S Anim Health Assoc; 1975; (79):70-84. PubMed ID: 1078068
    [No Abstract]   [Full Text] [Related]  

  • 37. The inhibitory effect of a dithiosemicarbazone on acute infections of Anaplasma marginale.
    Roby TO; Amerault TE; Spindler LA
    Res Vet Sci; 1968 Nov; 9(6):494-9. PubMed ID: 5719106
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparative efficacy of drugs in bovine anaplasmosis.
    Mishra AK; Sharma NN
    Trop Anim Health Prod; 1979 Nov; 11(4):222-6. PubMed ID: 552672
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anaplasma marginale infection in splenectomized calves.
    Jones EW; Norman BB; Kliewer IO; Brock WE
    Am J Vet Res; 1968 Mar; 29(3):523-33. PubMed ID: 5637919
    [No Abstract]   [Full Text] [Related]  

  • 40. Efficacy of a new oxytetracycline formulation against clinical anaplasmosis.
    Magonigle RA; Simpson JE; Frank FW
    Am J Vet Res; 1978 Sep; 39(9):1407-10. PubMed ID: 697150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.